Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer

K. Adam Morrow(University of South Alabama), Lalita A. Shevde(University of Alabama at Birmingham)
Oncotarget
February 19, 2016
Cited by 30


Related Papers